Drugs / Inactivated adjuvanted Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT00554333 Comparator | Oct → Dec 2007 | influenza | Sanofi Pasteur, a Sanofi Company | Completed | Mixed |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated adjuvanted Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00554333 ↗ |
| Modality | Vaccine | “Inactivated adjuvanted Influenza Vaccine for Intramuscular Route” NCT00554333 ↗ |
| Route | Intramuscular | “administered intramuscularly” PMID 20504306 ↗ May 2010 |